Brief report · Feb 2014
Byline
B. Board
Articles whose byline reads B. Board, printed as Bulletin Board. Different authors can share a byline.
- Articles
- 129
- Latest year
- 2014
Articles
Newest first. Showing 1–25 of 129 articles.
Brief report · Feb 2014
Dramatic reduction in joint inflammation promised by new compound
Brief report · Feb 2014
Postmenopausal women with rheumatoid arthritis and anti-CCP antibodies have higher mortality
Brief report · Feb 2014
Genetic basis of rheumatoid arthritis further defined
Brief report · Dec 2013
Bulletin Board
Brief report · Oct 2013
News & Events
Brief report · Aug 2013
Joint replacement surgery outcomes affected in those with rheumatoid arthritis
Brief report · Aug 2013
Overweight and obese patients are less likely to achieve remission in early rheumatoid arthritis
Brief report · Aug 2013
Novel mechanism of immune response regulation discovered
Brief report · Aug 2013
Nurse- led programs aid self- management of rheumatoid arthritis
Brief report · Jun 2013
Atomic force microscopy: a force for good in the understanding of osteoarthritis
Brief report · Jun 2013
Zoledronic acid: is there a cloud around the silver lining?
Brief report · Jun 2013
Risk of rheumatoid arthritis increases with years spent smoking and number of cigarettes
Brief report · Jun 2013
Childhood arthritis: study identifies 14 new genes as potential treatment targets
Brief report · Apr 2013
IRHOM2 identified as a new target for rheumatoid arthritis therapy
Brief report · Apr 2013
Fibromyalgia drugs found just as likely to harm as to help
Brief report · Apr 2013
Innate immunity sensor enzyme discovered
Brief report · Apr 2013
Adolescents who are double-jointed at increased risk of joint pain
Brief report · Feb 2013
Arthritis research breakthrough made
Brief report · Feb 2013
Rituximab could combat noncriteria manifestations of antiphospholipid syndrome
Brief report · Feb 2013
New study of the genetics of gout sheds light on the disease of kings
Brief report · Feb 2013
Two biologicals prove successful for systemic juvenile idiopathic arthritis in Phase III trials
Brief report · Dec 2012
Results from a Phase I/II study involving an anti-IL-6R nanobody in rheumatoid arthritis patients
Brief report · Dec 2012
Subcutaneous formulation of abatacept has been approved by the European Commission
Brief report · Dec 2012

